Insulin and neurodegenerative disease: shared and specific mechanisms

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994

Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072

Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,526

The Endocrine Regulation of Aging by Insulin-like Signals

Tatar, M., Bartke, A., & Antebi, A. (2003) · Science · doi:10.1126/science.1081447 · Cited by 1,327

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258

Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies

Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207

Insulin receptors are widely distributed in the central nervous system of the rat

Havránková, J., Roth, J., & Brownstein, M. (1978) · Nature · doi:10.1038/272827a0 · Cited by 1,116

Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes

Rulifson, E. J., Kim, S. K., & Nusse, R. (2002) · Science · doi:10.1126/science.1070058 · Cited by 1,064

Épidémiologie descriptive et étiologique

Elbaz, A., Artaud, F., Domenighetti, C., Hajji, M., Nguyen, T. T. H., Portugal, B., & Moisan, F. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78712-6.00002-6

Epigenetic Mediating Mechanisms in Parkinson's Disease: The Impact of Educational Attainment on SETD1A Expression

Yin, K., Gu, X., Yu, J., Su, W., Yang, W., Duan, Q., He, S., Shen, C., Lu, S., Chi, L., et al. (2025) · Movement Disorders · doi:10.1002/mds.70010

Cortical surface area as a stronger mediator of the waist-to-height ratio and cognitive impairment link in patients with first-episode schizophrenia compared to body mass index and waist-hip ratio

Chen, L., Yin, Y., Gou, M., Pan, S., Tong, J., Zhou, Y., Xie, T., Yu, T. Y., Li, Y., Cui, Y., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07458-z · Cited by 1

Astaxanthin: A promising nutraceutical for cardiovascular health

Daoud, M. S. (2025) · Journal of King Saud University - Science · doi:10.25259/jksus_512_2025

Risk of dementia in diabetes mellitus: a mechanistic endeavor

Samanta, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00029-3

Transcriptome analysis of Alzheimer's disease identifies links to cardiovascular disease

Ray, M. (2008) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7jw8c4j

Exploring the Association Between Depression and Obesity Among Alzheimer's Patients

Clugstone, S. (2014) · Scholar Commons (University of South Carolina)

Additional file 1 of Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease

Nasiri, E., Sankowski, R., Dietrich, H., Oikonomidi, A., Huerta, P. T., Popp, J., Al-Abed, Y., & Bacher, M. (2020) · Figshare · doi:10.6084/m9.figshare.12150948

The Role of Nutraceuticals in the Treatment of Neurodegenerative Diseases

Kumari, L., Datta, A., Sen, P., Dhara, S., & Badwaik, H. R. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898812553125010009

Long-term fasting insulin variability and cognitive function: Insights from the CARDIA study

Huang, B.-S., Huang, Z., Zeng, Y.-H., Bai, K.-H., Guo, J., Weng, J., Li, Z. H., & Hao, Q.-Y. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100487

POTENTIAL EFFECTS OF SGLT-2 INHIBITORS ON PARKINSON DISEASE

Baskın, V. (2026) · TOGÜ Sağlık Bilimleri Dergisi · doi:10.52369/togusagbilderg.1652318

Platelet proteomic signatures of amyloid β-positive mild cognitive impairment and Alzheimer’s disease

Cho, Y. E., Kim, A., Lee, H. M., Oh, J. W., Son, S. J., Roh, H. W., Jung, Y.-S., Hong, C. H., Lee, S. Y., & Kim, K. P. (2026) · Molecular Brain · doi:10.1186/s13041-026-01294-2

Synthèse et évaluation de nouveaux dérivés d'urées à base de tétrahydropyrido-isoindolones comme inhibiteurs de protéines kinases

Boulahjar, R. (2011) · doi:10.70675/dcc42e4fz2ef3z4e0dzbcebzdf2e57755187

Maladie d’Alzheimer et thérapies non médicamenteuses : évaluation de la stimulation cognitive et de l’activité physique sur le fonctionnement exécutif

Lapre, É. (2010) · theses.fr (ABES) · doi:10.70675/40963095z03f0z4c02zb5edzc76f2954590a

Cross-talk between insulin and serotonin signaling in the brain : Involvement of the PI3K/Akt pathway and behavioral consequences in models of insulin resistance

Papazoglou, I. (2013) · theses.fr (ABES) · doi:10.70675/06d278b5zf0a0z456dz9c4cz9dc680b45fd3 · Cited by 1

Impact et réversibilité du syndrome métabolique et de ses composantes sur le vieillissement cognitif et le risque de démence

Lévi, N. (2012) · theses.fr (ABES) · doi:10.70675/669f6173z0b7az47fezb1caz06aa7d109f5f

Dynamics of pathological aggregates and fibers

Pounot, K. (2020) · theses.fr (ABES) · doi:10.70675/b306d45azfd69z4b88z80c0z948cf17c885c

Caractérisation des mécanismes moléculaires impliqués dans la mise en place des altérations cérébrales dans un modèle préclinique de diabète de type 2

Hamzé, R. (2023) · theses.fr (ABES) · doi:10.70675/3ac7f72cz196fz4796z99a3z89271cd76677

Contribution à l'étude des facteurs de risque pour la maladie d'Alzheimer : analyse de candidats identifiés par étude d'association pangénomique ou GWAS

Bauer, C. (2023) · theses.fr (ABES) · doi:10.70675/0d82043ezd7c7z4fb4z9fc8ze2d05d18b02b

Multidimensional Classification of Insulin Resistance (MCIR) Focused on Therapeutic Targets and Interventions—A Comprehensive Review

Nowakowski, D., Zańko, A., Pawłowski, M., & Milewski, R. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135876

Polydatin inhibits hippocampal neurodegeneration in diabetic rats via modulation of oxidative stress and NF-kB/COX-2/IL-6 inflammatory pathway

Yousef, A. I., El-Twab, S. M. A., Khadrawy, S. M., Abdel‐Moneim, A., & Khalil, R. G. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01925-6

Prediction Model for Mild Cognitive Impairment in Older Chinese Patients With Cerebral Small Vessel Disease Based on XGBoost Algorithms and Shapley Additive Explanations

Gao, P., Su, J., Ma, X., Ma, X., Chen, Y., Shen, J., Wu, Y., Shi, C., & Li, J. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71044

WNKs regulate mouse behavior and alter central nervous system glucose uptake and insulin signalingPreprint

Jaykumar, A. B., Binns, D. D., Taylor, C. A., Anselmo, A. N., Kankanamalage, S. G., Birnbaum, S. G., Huber, K. M., & Cobb, M. H. (2026) · eLife · doi:10.7554/elife.100097.3

Safety and tolerability of intranasal insulin in Parkinson’s disease

Johnson, J. C., Kashyap, B., Gustafson, S. K., O’Brien, M., Frey, W. H., Svitak, A. L., & Hanson, L. R. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1875165

Association of Insulin Resistance and Metabolic Syndrome with Cognitive Impairment in Nonobese, Nondiabetic Older Adults: A Cross-Sectional Study

Macesic, M. V., Lalic, K. S., Lukić, L., Milicic, T. J., Stojmenović, G. M., Stojković, T., Gajović, J. S., Stoiljkovic, M. M., Milin-Lazovic, J. S., Milovancevic, M. M., et al. (2026) · Diabetology · doi:10.3390/diabetology7090186

Neuropsychiatric and neurocognitive outcomes of metformin versus insulin therapy in Egyptian patients with type 2 diabetes: focus on NGF and BDNF; a cross-sectional study

elaaty, T. A., Badrah, M., Elnily, D., & NAWAR, A. A. K. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00732-w

Retinal microvascular abnormalities and cognitive function in older people with type 2 diabetes

Ding, J. (2010) · Edinburgh Research Archive (University of Edinburgh)

Doctor of Nursing Practice portfolio of Rodica Malos

Malos, R. (2009) · doi:10.6083/m4513wz5

Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders

Ghasemi, R., Dargahi, L., Haeri, A., Moosavi, M., Mohamed, Z., & Ahmadiani, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8404-z · Cited by 123

Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches

Kellar, D., & Craft, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30231-3 · Cited by 832

Mechanisms of action of brain insulin against neurodegenerative diseases

Ramalingam, M., & Kim, S. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1147-1 · Cited by 30

Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?

Blum-Degen, D., Frölich, L., Hoyer, S., & Riederer, P. F. (1995) · PubMed · Cited by 55

Role of Insulin in Brain: An Emphasis on Molecular Functions

Kundu, S., & Firdous, S. M. (2022) · INNOSC Theranostics and Pharmacological Sciences · doi:10.36922/itps.v4i2.43 · Cited by 1